A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

May 22, 2025

Study Completion Date

May 22, 2025

Conditions
Parenteral Nutrition
Interventions
DRUG

Sodium Glycerophosphate Injection

Organic phosphate (SGP) will be diluted with 500mL of sodium chloride (0.9% normal saline) to achieve an equimolar IV phosphate dose of 60 mmol over 4 hours (h)

DRUG

Sodium Phosphates Injection

Inorganic phosphate (NaP) will be diluted with 500mL of sodium chloride (0.9% normal saline) to achieve an equimolar IV phosphate dose of 60 mmol over 4 h

Trial Locations (1)

78744

Austin PPD CRU, Austin

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT06842121 - A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP) | Biotech Hunter | Biotech Hunter